A Pilot Study of Clofarabine Pre-Conditioning Prior to Full or Reduced Intensity Allogeneic Transplantation in the Treatment of High Risk Acute Myeloid Leukaemia and Myelodysplasia.

Trial Profile

A Pilot Study of Clofarabine Pre-Conditioning Prior to Full or Reduced Intensity Allogeneic Transplantation in the Treatment of High Risk Acute Myeloid Leukaemia and Myelodysplasia.

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 23 Nov 2016

At a glance

  • Drugs Clofarabine (Primary)
  • Indications Acute myeloid leukaemia; Myelodysplastic syndromes
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 12 Oct 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2017.
    • 12 Oct 2016 Status changed from recruiting to active, no longer recruiting.
    • 24 Aug 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01422603).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top